Fernando Rivero retweeted
Proud to present the ESP-INOCA registry at the COVADIS Meeting.
A truly collaborative project that continues to grow thanks to the incredible network of investigators across Spain 🇪🇸. @shci_sec
@ramonlopezpalop @fer_iver @ainhoape1 @piserraggs @AnaPardo213 @JuradoRomanAl @Guimacardio @cardioyoguini @JonZubiaur @CarlosCortes @sbrugaletta @ErnestoValero84 @EstefaniaFdezP3 @TelleriaMiren @ManuelaRV1981 @josepgomezlara
Fernando Rivero retweeted
In the Spanish SCAD Registry, LAD involvement identified a higher-risk SCAD phenotype, characterised by more complex angiographic features, greater myocardial injury, and an increased risk of long-term adverse cardiovascular events.
Read full paper here: eurointervention.pcronline.c…
@maitevelazquezm @macayaten @OjedaOjeda18 @CamachoFreire @teresabastante @David_delVal_ @rajivxgulati
#SCAD #CoronaryArteryDisease
Fernando Rivero retweeted
Severe scaffold collapse may occur even with new-generation bioresorbable magnesium scaffolds.
This multimodality intracoronary imaging case documents restenosis secondary to scaffold collapse 6 months after implantation, highlighting the importance of meticulous implantation technique and optimisation.
eurointervention.pcronline.c…
@teresabastante
Fernando Rivero retweeted
Tomografía de coherencia óptica en el diagnóstico y el tratamiento de la trombosis del stent #recintervcardiol @paulantun @CCuesta2 @fer_iver @teresabastante @Guimacardio @David_delVal_ @AfMarschall @moriscesar @PabloAvanzas @shci_sec recintervcardiol.org/es/arti…
Fernando Rivero retweeted
Does the clinical benefit of intravascular imaging-guided PCI differ between focal & diffuse CAD? A LBCT presented at #EuroPCR & published simultaneously @ColinBerryMD @wfearonmd @divaka_perera @fer_iver @juliendjdj @SimoneBiscaglia @DrAllenJ @DMunhoz ahajrnls.org/3Ps2jPh
Fernando Rivero retweeted
DCB angioplasty for bypass graft failure: feasible across de novo and ISR lesions.
In this multicentre registry, 2-year TLR was 11%, with no bailout stenting required.
Read more here 👉 eurointervention.pcronline.c…
@AfMarschall @NievesGonzalo1 @fer_iver @pabl0salinas @Felipediezhoyo @JEscaned @macayaten
#CardioTwitter #PCI
Fernando Rivero retweeted
Patterns of Disease, Pullback Pressure Gradient, and Residual Angina at One-Year. Will PPG define future revascularization strategies? @ColinBerryMD @BernardBruyne @wfearonmd @divaka_perera @GianlucaCampo78 @fer_iver @juliendjdj @DrAllenJ @T_Storozhenko
ahajrnls.org/3NPskXE
Fernando Rivero retweeted
Estrategia de reducción de stents frente a revascularización coronaria percutánea convencional en el IAMCEST: diseño del ensayo COPERNICAN #REC @sjorge4 @drassantos @EvaRumiz @AntonioGomezM21 @fer_iver @cardioyoguini @hect2701 @Borjaibanez1 @ignamatsant revespcardiol.org/es-estrate…
Fernando Rivero retweeted
Distal occlusion of a marginal branch in a 38-y-o 👩. No CVRF. SCAD? Coronary embolism? In situ atherothrombosis? Bilateral iliac artery FMD supports SCAD, with implications for management and prognosis. Nice example of how screening for FMD can help refine the diagnosis of SCAD.
Fernando Rivero retweeted
Optical coherence tomography for the diagnosis and management of stent thrombosis. #recintervcardiol #Aheadofprint @paulantun @CCuesta2 @fer_iver @teresabastante @Guimacardio @David_delVal_ @AfMarschall @moriscesar @PabloAvanzas recintervcardiol.org/en/orig…
Fernando Rivero retweeted
Can a physiology-based prediction model using FFR & pullback pressure gradient predict outcomes following PCI? Presented @crfheart #TCT2025 and published simultaneously @ColinBerryMD @wfearonmd #AHAJournals @keulards @juliendjdj @DrAllenJ @fer_iver
ahajrnls.org/47qe4uk
Fernando Rivero retweeted
Can we rule out coronary microvascular dysfunction from just one angiographic view? 🤔
Our new study introduces a Murray’s law–based approach for assessing coronary microvasculature in INOCA patients.
Thrilled to share the results!
kwnsfk27.r.eu-west-1.awstrac…
@IJCardio @fer_iver
The wireless approach to coronary #MVD can be very attractive but, be careful, use with caution!!
Can we rule out coronary microvascular dysfunction from just one angiographic view? 🤔
Our new study introduces a Murray’s law–based approach for assessing coronary microvasculature in INOCA patients.
Thrilled to share the results!
kwnsfk27.r.eu-west-1.awstrac…
@IJCardio @fer_iver
Fernando Rivero retweeted
"En el ensayo OPTION-STEMI se observó una interacción significativa con la clase Killip, lo que sugiere un mayor riesgo en pacientes con insuficiencia cardiaca aguda", destaca @fer_iver. #BlogSEC @jovenesSEC ow.ly/aR4x50X9zuz
Fernando Rivero retweeted
The PLATEBRISK study suggests that a simplified antithrombotic regimen after #LAAO is as effective as conventional treatment for high bleeding risk patients, with a lower rate of major bleeding in those with a history of bleeding. @pjantunez #EIJBestOf
ow.ly/1xkM50T5u3a
Fernando Rivero retweeted
VI Madrid DCB Meeting 📚
📌Learning about drug coated balloon coronary therapy from leading national and international experts #HospitallaPrincesa
@shci_sec @NievesGonzalo1 @teresabastante @OjedaOjeda18 @JuradoRomanAl @maitevelazquezm @fer_iver @paulantun @PCRonline
Fernando Rivero retweeted
Disección coronaria espontánea y enfermedad ateroesclerótica concomitante #REC @teresabastante
revespcardiol.org/es-disecci…
One week left to learn from the world's leading experts in #DEB. We await you in Madrid #2025DEBMadrid
Fernando Rivero retweeted
Desde el grupo de trabajo de diagnóstico intracoronario @EvaRumiz nos presenta el estudio ESP-INOCA
@shci_sec @secardiologia
Fernando Rivero retweeted
El Dr. Fernando Rivero Crespo (H. U. de La Princesa) en la presentación del informe del grupo de trabajo de intracoronario.
#ACISEC2025 #ReuniónAdministrativa
